Free Trial
LON:DOCS

Dr. Martens (DOCS) Share Price, News & Analysis

Dr. Martens logo
GBX 66.20 -0.05 (-0.07%)
As of 02/21/2025 12:45 PM Eastern

About Dr. Martens Stock (LON:DOCS)

Key Stats

Today's Range
65.40
67.25
50-Day Range
65.60
76.70
52-Week Range
49.32
100
Volume
428,912 shs
Average Volume
1.61 million shs
Market Capitalization
£642.66 million
P/E Ratio
9.38
Dividend Yield
4.53%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Dr. Martens is an iconic British brand founded in 1960 in Northamptonshire. Originally produced for workers looking for tough, durable boots, the brand was quickly adopted by diverse youth subcultures and associated musical movements. Dr. Martens have since transcended their working-class roots while still celebrating their proud heritage and, six decades later, “Docs” or “DMs” are worn by people around the world who use them as a symbol of empowerment and their own individual attitude. The Company successfully listed on the main market of the London Stock Exchange on 29 January 2021 (DOCS.L) and is a constituent of the FTSE 250 index. Dr. Martens operates across three geographic regions: EMEA, Americas and APAC. Our product segments include Originals, Fusion, Kids and Casual and a complementary range of Accessories.

Receive DOCS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Dr. Martens and its competitors with MarketBeat's FREE daily newsletter.

DOCS Stock News Headlines

Dr. Martens plc (LON:DOCS) Insider Acquires 207 Shares
Watch This Robotics Demo Before March 17th
Jeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%... Just did a demo of what Nvidia’s CEO said will be "the first multitrillion-dollar robotics industry."
Barclays Sticks to Their Hold Rating for Dr. Martens Plc (DOCS)
Goldman Sachs Keeps Their Hold Rating on Dr. Martens Plc (DOCS)
See More Headlines

DOCS Stock Analysis - Frequently Asked Questions

Dr. Martens' stock was trading at GBX 72.20 at the beginning of the year. Since then, DOCS stock has decreased by 8.3% and is now trading at GBX 66.20.
View the best growth stocks for 2025 here
.

Dr. Martens plc (LON:DOCS) announced its earnings results on Thursday, November, 28th. The company reported ($1.30) earnings per share for the quarter. Dr. Martens had a trailing twelve-month return on equity of 18.91% and a net margin of 7.89%.

Shares of DOCS stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Based on aggregate information from My MarketBeat watchlists, some other companies that Dr. Martens investors own include boohoo group (BOO), Aston Martin Lagonda Global (AML), ASOS (ASC), Vodafone Group Public (VOD), JD Sports Fashion (JD), Legal & General Group (LGEN) and Lloyds Banking Group (LLOY).

Company Calendar

Last Earnings
11/28/2024
Today
2/21/2025
Ex-Dividend for 4/8 Dividend
3/06/2025
Dividend Payable
4/08/2025

Industry, Sector and Symbol

Industry
Footwear & Accessories
Sub-Industry
Computer Software
CIK
N/A
Fax
N/A
Employees
890
Year Founded
N/A

Profitability

Net Income
£68.97 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£874.20 million
Cash Flow
GBX 4.63 per share
Book Value
GBX 37.80 per share

Miscellaneous

Free Float
N/A
Market Cap
£642.66 million
Optionable
Not Optionable
Beta
0.11
20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio?

Get This Free Report

This page (LON:DOCS) was last updated on 2/22/2025 by MarketBeat.com Staff
From Our Partners